Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia

NCT00773149 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphocytic Leukemia

Interventions

DRUG: Alemtuzumab (CAMPATH 1H) associated to G-CSF

Sponsor

Assistance Publique - Hôpitaux de Paris